Suppr超能文献

G蛋白偶联受体激酶和β-抑制蛋白对δ-阿片受体转运的激动剂特异性调节

Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin.

作者信息

Zhang J, Ferguson S S, Law P Y, Barak L S, Caron M G

机构信息

Howard Hughes Medical Institute Laboratories, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):301-13. doi: 10.3109/10799899909036653.

Abstract

Opioid receptors mediate multiple biological functions through their interaction with endogenous opioid peptides as well as opioid alkaloids including morphine and etorphine. Previously we have reported that the ability of distinct opioid agonists to differentially regulate mu-opioid receptor (mu OR) responsiveness is related to their ability to promote G protein-coupled receptor kinase (GRK)-dependent phosphorylation of the receptor (1). In the present study, we further examined the role of GRK and beta-arrestin in agonist-specific regulation of the delta-opioid receptor (delta OR). While both etorphine and morphine effectively activate the delta OR, only etorphine triggers robust delta OR phosphorylation followed by plasma membrane translocation of beta-arrestin and receptor internalization. In contrast, morphine is unable to either elicit delta OR phosphorylation or stimulate beta-arrestin translocation, correlating with its inability to cause delta OR internalization. Unlike for the mu OR, overexpression of GRK2 results in neither the enhancement of delta OR sequestration nor the rescue of delta OR-mediated beta-arrestin translocation. Therefore, our findings not only point to the existence of marked differences in the ability of different opioid agonists to promote delta OR phosphorylation by GRK and binding to beta-arrestin, but also demonstrate differences in the regulation of two opioid receptor subtypes. These observations may have important implications for our understanding of the distinct ability of various opioids in inducing opioid tolerance and addiction.

摘要

阿片受体通过与内源性阿片肽以及包括吗啡和埃托啡在内的阿片生物碱相互作用来介导多种生物学功能。此前我们曾报道,不同阿片类激动剂对μ-阿片受体(μOR)反应性进行差异调节的能力与其促进受体的G蛋白偶联受体激酶(GRK)依赖性磷酸化的能力有关(1)。在本研究中,我们进一步研究了GRK和β-抑制蛋白在δ-阿片受体(δOR)激动剂特异性调节中的作用。虽然埃托啡和吗啡都能有效激活δOR,但只有埃托啡能引发强烈的δOR磷酸化,随后β-抑制蛋白发生质膜转位以及受体内化。相比之下,吗啡既不能引发δOR磷酸化,也不能刺激β-抑制蛋白转位,这与其无法导致δOR内化相关。与μOR不同,GRK2的过表达既不会增强δOR的隔离,也不会挽救δOR介导的β-抑制蛋白转位。因此,我们的研究结果不仅表明不同阿片类激动剂在通过GRK促进δOR磷酸化以及与β-抑制蛋白结合的能力上存在显著差异,还证明了两种阿片受体亚型在调节上的差异。这些观察结果可能对我们理解各种阿片类药物在诱导阿片耐受和成瘾方面的不同能力具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验